(Bloomberg) — Eli Lilly agreed to buy Waltham-based gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some ...
Eli Lilly LLY-0.60%decrease; red down pointing triangle has agreed to buy biopharmaceutical company Morphic Holding MORF 0.02%increase; green up pointing triangle for $3.2 billion in a deal ...
Eli Lilly says it will acquire a Waltham-based drug company that's working on a treatment for inflammatory bowel disease.
Eli Lilly on Monday announced a $3.2 billion all-cash deal to purchase Morphic and its pipeline of oral integrin therapies in ...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...
Eli Lilly (LLY) offers to acquire Morphic Therapeutics for $3.2 billion. Pfizer (PFE) selects a once-daily formulation of danuglipron for further development as a weight loss pill. Is Eli ...
Eli Lilly (LLY) offers to acquire Morphic Therapeutics for $3.2 billion. Pfizer (PFE) selects a once-daily formulation of ...